Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial

Targeted axillary dissection (TAD) is an established method for axillary staging in patients with breast cancer after neoadjuvant chemotherapy (NAC). TAD consists of sentinel lymph node biopsy and initially pa...

Source: World Journal of Surgical Oncology - August 19, 2023 Category: Cancer & Oncology Authors: Jan Žatecký, Oldřich Coufal, Ondřej Zapletal, Otakar Kubala, Markéta Kepičová, Adéla Faridová, Karel Rauš, Jiří Gatěk, Peter Kosáč and Matúš Peteja Tags: Research Source Type: research